Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab--monitoring of antiphospholipid and anti-GP antibodies: a case report.
Trappe
R
R
Loew
A
A
Thuss-Patience
P
P
Dörken
B
B
Riess
H
H
D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000096:biosynthesis*; D016736:Antiphospholipid Syndrome / Q000628:therapy*; D001777:Blood Coagulation; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007075:Immunoglobulin M / Q000378:metabolism; D007155:Immunologic Factors / Q000494:pharmacology; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D000069283:Rituximab; D013921:Thrombocytopenia / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007075:Immunoglobulin M; D007155:Immunologic Factors; D000069283:Rituximab